Co-Diagnostics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Co-Diagnostics, Inc. (CODX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-37.64-35.33-14.2436.6642.48
Depreciation & Amortization1.381.231.280.340.14
Deferred Income Tax0.00-2.42-4.810.93-0.55
Stock Based Compensation5.438.347.545.512.74
Change in Working Capital2.755.646.19-2.90-16.82
Change in Accounts Receivable0.192.5414.92-8.74-12.96
Change in Inventory0.270.41-3.675.71-7.92
Change in Accounts Payable2.161.25-4.69-0.303.76
Change in Other Working Capital0.41-3.46-12.68-2.05-0.01
Other Operating Activities-0.37-3.46-12.680.933.69
Net Cash from Operating Activities-29.16-22.086.5741.0828.17
Investing Activities
Capital Expenditures-0.75-1.37-1.43-0.670.77
Acquisitions-0.140.000.001.20-0.71
Purchases of Investments17.82-110.50-68.003.57-5.05
Sales/Maturities of Investments58.77127.2511.263.08-5.05
Other Investing Activities0.000.000.000.49-0.71
Net Cash from Investing Activities17.0715.39-58.174.10-5.82
Financing Activities
Common Stock Issued0.100.000.180.4519.47
Common Stock Repurchased0.00-1.36-14.210.000.00
Other Financing Activities0.000.000.000.451.73
Net Cash from Financing Activities0.10-1.36-14.030.4519.74
Summary
Net Change in Cash-11.98-8.06-65.6345.6342.08
Cash at Beginning of Period14.9222.9788.6142.980.89
Cash at End of Period2.9414.9222.9788.6142.98
Free Cash Flow-29.90-23.455.1440.4127.39
Supplemental Disclosures
Income Taxes Paid0.000.064.505.400.00